Nuvalent (NUVL) Investor Presentation - Slideshow

Corporate Overview March 2022 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes "forward looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, implied and expressed statements about our strategy, business plans, and focus; the progress and timing of the preclinical and clinical development of our programs, including NVL-520 and NVL-655; the potential clinical effect of NVL-520 and NVL-655; the ...